Latest Period
n/a
Security Snapshot
Indaptus Therapeutics, Inc. - Common Stock, $0.01 par value (INDP) Institutional Ownership
CUSIP: 45339J105
13F Institutional Holders and Ownership History from Q3 2021 to Q2 2025
Institutions Reporting
Shares (Excl. Options)
Price
$0.46
Save this security page for your next review
Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.
- Type / Class
- Equity / Common Stock, $0.01 par value
- Symbol
- INDP on Nasdaq
- Shares outstanding
- 113,183,288
- Price per share
- $0.46
- Price from insider filings
- $0.46
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Quick Takeaways
- INDP - Indaptus Therapeutics, Inc. - Common Stock, $0.01 par value is tracked under CUSIP 45339J105.
- Latest finished 13F holder period is not available.
- 4 significant owners is listed from Schedule 13D/13G reporting.
What Changed
- Holder count moved from 17 to 0 between Q1 2025 and Q2 2025.
- Reported value moved from $353,682 to $0.
Why This Matters
- You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
- 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.
Source Evidence
Source: SEC Schedule 13D/G
Open SEC Evidence
Ownership context comes from Schedule 13D/G and available holder history for this CUSIP.
Investment Quick Answers
What is CUSIP 45339J105?
CUSIP 45339J105 identifies INDP - Indaptus Therapeutics, Inc. - Common Stock, $0.01 par value in SEC 13F datasets.
Where can I see the latest institutional holders?
Use the ownership history tables below to review the newest available institutional filing periods.
Next ownership checks
Use the next link that matches the question you still need to answer about this security.
- Latest 13F filings when you want to inspect fresh institutional portfolio moves.
- Latest Schedule 13D/13G reports when you need large-owner changes outside the 13F cycle.
- All institutional ownership pages to compare this security with other holder-history pages.
Recent Quarterly Holder Reports
Open recent reporting periods for CUSIP 45339J105:
Significant Owners of Indaptus Therapeutics, Inc. - Common Stock, $0.01 par value (INDP) based on Schedule 13D/G filings
| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| Yao Yun | 37% | -1.8% | $19,315,860 | 41,991,000 | 0% | Yao Yun | 28 Apr 2026 | |
| Lazar David E. | 48% | -51% | $949,440 | -$50,110,560 | 2,064,000 | -98% | Lazar David E. | 23 Mar 2026 |
| Meckler Jeffrey A | 13% | $125,627 | 273,103 | Jeffery A. Meckler | 22 Dec 2025 | |||
| Newman Michael James | 5.4% | $53,154 | 115,552 | Newman Michael James | 22 Dec 2025 |
Institutional Holders of Indaptus Therapeutics, Inc. - Common Stock, $0.01 par value (INDP) across Reporting Periods
| Period | Reported Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2025 Q2 | 0 | $0 | -$353,682 | $0.46 | 0 |
| 2025 Q1 | 643,262 | $353,682 | +$16,672 | $0.55 | 17 |
| 2024 Q4 | 638,409 | $539,564 | +$18,707 | $0.84 | 19 |
| 2024 Q3 | 605,020 | $750,238 | +$5,985 | $1.24 | 17 |
| 2024 Q2 | 599,915 | $1,262,320 | +$23,925 | $2.12 | 21 |
| 2024 Q1 | 587,768 | $1,314,120 | -$24,471 | $2.24 | 17 |
| 2023 Q4 | 602,239 | $1,058,915 | +$56,020 | $1.76 | 18 |
| 2023 Q3 | 570,529 | $1,569,014 | -$25,658 | $2.76 | 16 |
| 2023 Q2 | 583,740 | $1,109,616 | +$8,428 | $1.91 | 15 |
| 2023 Q1 | 579,339 | $1,079,449 | -$60,057 | $1.85 | 15 |
| 2022 Q4 | 576,419 | $838,524 | +$5,682 | $1.45 | 16 |
| 2022 Q3 | 566,356 | $1,222,000 | +$141,749 | $2.17 | 12 |
| 2022 Q2 | 500,710 | $1,306,000 | -$3,185,888 | $2.61 | 12 |
| 2022 Q1 | 1,687,829 | $6,751,000 | -$661,036 | $4.00 | 9 |
| 2021 Q4 | 1,836,196 | $10,466,000 | +$6,508,484 | $5.70 | 11 |
| 2021 Q3 | 541,295 | $4,239,000 | +$4,239,000 | $7.83 | 9 |